Press releaseBusiness Wire
Rockwell Medical
RMTI · NASDAQ
$7.23−$0.26 (−3.47%)TodayMarket closed ·
Prev close $7.49
Latest news
- Press releaseBusiness Wire
Rockwell Medical to Exhibit at ASN Kidney Week 2026
- Press releaseBusiness Wire
Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production’ List
- Press releaseBusiness Wire
Rockwell Medical Announces Second Quarter 2026 Results
- Press releaseBusiness Wire
Rockwell Medical Advances Quality and Regulatory Leadership
- Press releaseBusiness Wire
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
- Press releaseBusiness Wire
Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026
- Press releaseBusiness Wire
Rockwell Medical Announces 1-for-10 Reverse Stock Split
- Press releaseBusiness Wire
Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis
- Press releaseBusiness Wire
Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis
- Press releaseBusiness Wire
Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability
- Press releaseBusiness Wire
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
Earnings Scheduled For March 26, 2026
- Press releaseBusiness Wire
Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseBusiness Wire
Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026
- Press releaseBusiness Wire
Rockwell Medical Named 'Great Place to Work' for Fourth Year in a Row
- Press releaseBusiness Wire
Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results
- Press releaseBusiness Wire
Rockwell Medical Adds 30 New Customers in the West
- Press releaseBusiness Wire
Rockwell Medical Extends Product Purchase Agreement Through 2026 With One of the Largest Dialysis Providers in the United States
- Press releaseBusiness Wire
Rockwell Medical Appoints Joe Dawson to the Company's Board of Directors
- News
Earnings Scheduled For November 12, 2025
- Press releaseBusiness Wire
Rockwell Medical Announces Third Quarter 2025 Results
- Press releaseBusiness Wire
Rockwell Medical Names Rashad Brown Vice President, Manufacturing and Supply Chain
- Press releaseBusiness Wire
Rockwell Medical to Exhibit at ASN Kidney Week 2025
- Press releaseBusiness Wire
Rockwell Medical Named Fortune 'Best Workplaces in Manufacturing & Production' Second Year in a Row
- Press releaseBusiness Wire
Rockwell Medical to Release Third Quarter 2025 Results on Wednesday, November 12, 2025
- Press releaseBusiness Wire
Rockwell Medical Promotes Heather Hunter to Chief Operating Officer
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
- News
Rockwell Medical Q2 Adj. EPS $(0.01) Beats $(0.05) Estimate, Sales $16.071M Miss $16.332M Estimate
- News
Earnings Scheduled For August 14, 2025
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseBusiness Wire
Rockwell Medical Adds Single-Use Bicarbonate Cartridge to Hemodialysis Concentrates Product Portfolio
- Press releaseGlobe Newswire
UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
- Press releaseGlobe Newswire
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
- Press releaseBusiness Wire
Rockwell Medical Promotes Jesse Neri to Chief Financial Officer
- News
What Analysts Are Saying About Rockwell Medical Stock
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.